Meritech Capital Associates V L.L.C. / TXG
Meritech Capital Associates V L.L.C.’s 10x Genomics Inc Position
Does Meritech Capital Associates V L.L.C. own 10x Genomics Inc (TXG)? Not currently — the last reported position was 494.2K shares worth $10M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$10M
Q2 2024
Shares
494.2K
% of Portfolio
+3.30%
Quarters Held
15
position exited
Position History TXG
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 494.2K | $10M | +3.30% |
| Q1 2024 | 494.2K | $19M | +6.20% |
| Q4 2023 | 494.2K | $28M | +6.73% |
| Q3 2023 | 494.2K | $20M | +6.49% |
| Q2 2023 | 750.5K | $42M | +10.04% |
| Q1 2023 | 750.5K | $42M | +8.80% |
| Q4 2022 | 1.06M | $39M | +9.44% |
| Q3 2022 | 1.06M | $30M | +5.16% |
| Q2 2022 | 1.06M | $48M | +7.43% |
| Q1 2022 | 1.34M | $102M | +9.59% |
| Q4 2021 | 1.61M | $240M | +7.68% |
| Q3 2021 | 1.79M | $261M | +7.80% |
| Q2 2021 | 1.79M | $351M | +7.51% |
| Q1 2021 | 2.12M | $384M | +9.49% |
| Q4 2020 | 2.58M | $365M | +30.70% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meritech Capital Associates V L.L.C.’s full portfolio or all institutional holders of TXG.